Drug-induced lupus erythematosus secondary to nafcillin: the first reported case.
Rheumatol Int
; 24(4): 242-3, 2004 Jul.
Article
en En
| MEDLINE
| ID: mdl-14658003
ABSTRACT
With an estimated incidence of 15-30,000 cases per year in the United States, drug-induced lupus erythematosus (DIL) is an uncommon iatrogenic condition. The number of implicated medications increases each year. We report the first case of DIL secondary to nafcillin administration in a patient with a prosthetic aortic valve and methicillin-sensitive Staphylococcus aureus who developed a facial rash and lower back pain.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Lupus Eritematoso Sistémico
/
Antibacterianos
/
Nafcilina
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Rheumatol Int
Año:
2004
Tipo del documento:
Article
País de afiliación:
Estados Unidos